Central Nervous System Effects of HMG CoA Reductase Inhibitors: Lovastatin and Pravastatin on Sleep and Cognitive Performance in Patients with Hypercholesterolemia-Reference-Cited by-同舟云学术

Central Nervous System Effects of HMG CoA Reductase Inhibitors: Lovastatin and Pravastatin on Sleep and Cognitive Performance in Patients with Hypercholesterolemia

Published:1994-10 Issue:10 Volume:34 Page:989-996
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Kostis John B.,Rosen Raymond C.,Wilson Alan C.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1994.tb01971.x/fullpdf

Reference31 articles.

1. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia: additive effective of compactin and cholestyramine;Mabuchi;N Engl J Med,1983

2. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia: a multicenter study.;The Lovastatin Study Group;JAMA,1986

3. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing;Hunninghake;Atherosclerosis,1990

4. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia;Grundy;N Engl J Med,1988

5. Pravastatin and simvastatin differently inhibit cholesterol biosynthesis in human lens;Vries;Invest Ophthalmol Vis Sci,1993

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning approach to personalized predictors of dyslipidemia: a cohort study;Frontiers in Public Health;2023-09-20

2. Pravastatin for lowering lipids;Cochrane Database of Systematic Reviews;2023-09-18

3. Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis;European Journal of Preventive Cardiology;2021-11-25

4. Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: A systematic review and meta-analysis;Ageing Research Reviews;2020-01

5. Evidence and mechanisms for statin-induced cognitive decline;Expert Review of Clinical Pharmacology;2019-04-27